Creative Planning’s Gilead Sciences GILD Stock Holding History

Creative Planning’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500	Closed	-$4K	–	2392
2020 Q3	$4K	Sell	500 -1,000	-67%	-$69.3K	﹤0.01%	2054
2020 Q2	$1K	Buy	+1,500	New	+$115K	﹤0.01%	1987
2017 Q3	–	Sell	-3,000	Closed	-$3K	–	2602
2017 Q2	$3K	Buy	+3,000	New	+$200K	﹤0.01%	4183
2017 Q1	–	Sell	-37,000	Closed	-$531K	–	4751
2016 Q4	$531K	Sell	37,000 -2,800	-7%	-$208K	﹤0.01%	891
2016 Q3	$385K	Buy	39,800 +1,900	+5%	+$154K	﹤0.01%	1032
2016 Q2	$360K	Buy	37,900 +20,000	+112%	+$1.77M	﹤0.01%	937
2016 Q1	$142K	Sell	17,900 -10,000	-36%	-$902K	﹤0.01%	1415
2015 Q4	$118K	Sell	27,900 -12,600	-31%	-$1.31M	﹤0.01%	1533
2015 Q3	$293K	Hold	40,500	–	–	﹤0.01%	987
2015 Q2	$139K	Buy	40,500 +4,800	+13%	+$524K	﹤0.01%	941
2015 Q1	$214K	Buy	35,700 +10,200	+40%	+$1.04M	﹤0.01%	1160
2014 Q4	$277K	Buy	25,500 +20,000	+364%	+$2.07M	﹤0.01%	976
2014 Q3	$54K	Buy	+5,500	New	+$539K	﹤0.01%	1870

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Creative Planning's GILD Position: Q2 2026 in Review

Creative Planning increased its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, buying an estimated $656K and bringing the position to 414,367 shares worth $52.4M. The position accounts for 0.03% of the portfolio, ranked #234.

Creative Planning first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $57.1M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Creative Planning held 414,367 shares of Gilead Sciences worth $52.4M as of Q2 2026.
Creative Planning bought 4,976 Gilead Sciences shares in Q2 2026, an estimated $656K.
Gilead Sciences made up 0.03% of Creative Planning's portfolio in Q2 2026, its #234 holding.
Creative Planning first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Creative Planning's Gilead Sciences position peaked at $57.1M in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.